232 related articles for article (PubMed ID: 31541382)
21. Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen.
Ozşener S; Ozaran A; Itil I; Dikmen Y
Eur J Gynaecol Oncol; 1998; 19(6):580-3. PubMed ID: 10215447
[TBL] [Abstract][Full Text] [Related]
22. Hysteroscopic Evaluation of Endometrial Changes in Breast Cancer Women with or without Hormone Therapies: Results from a Large Multicenter Cohort Study.
Chiofalo B; Mazzon I; Di Angelo Antonio S; Amadore D; Vizza E; Laganà AS; Vocaturo G; Calagna G; Favilli A; Palmara V; Maranto M; Vitale SG; Cucinella G; Granese R; Ghezzi F; Sperduti I; Triolo O
J Minim Invasive Gynecol; 2020; 27(4):832-839. PubMed ID: 31425735
[TBL] [Abstract][Full Text] [Related]
23. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
[TBL] [Abstract][Full Text] [Related]
24. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
Cohen I
Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
26. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
27. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
Archer DF
Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
[No Abstract] [Full Text] [Related]
28. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
[TBL] [Abstract][Full Text] [Related]
29. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
30. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
31. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
[TBL] [Abstract][Full Text] [Related]
32. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of endometrium during tamoxifen therapy of breast cancer].
Obrebowska A; Sibila-Owczarska A; Sajdak S
Ginekol Pol; 2002 Nov; 73(11):1109-12. PubMed ID: 12722407
[TBL] [Abstract][Full Text] [Related]
34. Pathology of endometrium treated with tamoxifen.
Ismail SM
J Clin Pathol; 1994 Sep; 47(9):827-33. PubMed ID: 7962652
[TBL] [Abstract][Full Text] [Related]
35. [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients].
Ashtrafian LA; Antonova IB; Chazova NL; Motskobili TA; Babaeva NA; Al'ditskiĭ IA
Vopr Onkol; 2005; 51(2):200-5. PubMed ID: 16223001
[TBL] [Abstract][Full Text] [Related]
36. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen-induced uterine abnormalities: the role of imaging.
Ascher SM; Imaoka I; Lage JM
Radiology; 2000 Jan; 214(1):29-38. PubMed ID: 10644098
[TBL] [Abstract][Full Text] [Related]
38. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
[TBL] [Abstract][Full Text] [Related]
39. Elastosonographic evaluation of endometrium in women using tamoxifen for breast cancer.
Gultekin IB; Imamoglu GI; Gultekin S; Yilmaz EA; Yilmaz Z; Alkan A; Kucukozkan T
Niger J Clin Pract; 2019 Jan; 22(1):92-100. PubMed ID: 30666026
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]